Cargando…

Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China

BACKGROUND: Several rescue therapies have been used in patients with lamivudine (LAM)-resistant chronic hepatitis B (CHB); however, the economic outcome of these therapies is unclear. The object of the current analysis was to evaluate the lifetime cost-effectiveness of rescue therapies among patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bin, Shen, Jinfang, Cheng, Huafeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511237/
https://www.ncbi.nlm.nih.gov/pubmed/23137013
http://dx.doi.org/10.1186/1472-6963-12-385